Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Operating Expenses (2016 - 2023)

Altimmune (ALT) has disclosed Other Operating Expenses for 9 consecutive years, with $12.4 million as the latest value for Q4 2023.

  • Quarterly Other Operating Expenses changed N/A to $12.4 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $12.4 million through Sep 2024, changed N/A year-over-year, with the annual reading at $12.4 million for FY2023, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2023 was $12.4 million at Altimmune, up from $3.3 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $12.4 million in Q4 2023, with the low at $1.0 million in Q3 2019.
  • Average Other Operating Expenses over 3 years is $6.2 million, with a median of $5.7 million recorded in 2021.
  • Peak annual rise in Other Operating Expenses hit 83.81% in 2019, while the deepest fall reached 83.81% in 2019.
  • Over 3 years, Other Operating Expenses stood at $1.0 million in 2019, then skyrocketed by 230.0% to $3.3 million in 2021, then surged by 276.33% to $12.4 million in 2023.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $12.4 million, $3.3 million, and $8.1 million for Q4 2023, Q4 2021, and Q2 2021 respectively.